In this episode, we talk to Paul L. Eugenio, MD, Electrophysiology, and Ronen Harel, DO, Hematology & Oncology, about anticoagulation therapy, treating A-Fib, new medications in AC, and bridge therapy in the surgical setting.  

Discussion:

• Common indications for anticoagulation therapy (cardiology, non-cardiology)
• What’s new in anticoagulation, what are the new medications?
• How to treat A-fib so that AC is no longer needed
• Therapeutic Options
• The role of aspirin
• How to handle surgery and bridge therapy 

Resources:
AC in elective surgeries
Stopping DOAC Preop

About Jonathan Nasser, MD
Jonathan Nasser, MD is the President of Crystal Run Healthcare. Dr. Nasser is Board Certified in Pediatrics and Internal Medicine. He earned his Medical Degree from the University of Virginia in Charlottesville, VA, and completed his Residency at the University of Rochester Medical Center in Rochester, NY. As a Physician Executive for the last ten years, he has served in many clinical and operational leadership roles for Crystal Run, most recently serving as the Chief Clinical Integration Officer of Crystal Run Healthcare and Executive Director of Crystal Run Ambulatory Surgery Center, until being named President in 2023. As President, Dr. Nasser oversees the executive team and works directly with Crystal Run’s Managing Partner and CEO, Hal Teitelbaum, MD, JD, MBA, to successfully implement the Practice’s strategic goals. Dr. Nasser has been responsible for instituting clinical programs to support Crystal Run’s transition from a fee-for-service to a value-based care organization. He has presented this work in numerous forums, including national meetings with the American Medical Group Association (AMGA) and Group Practice Improvement Network (GPIN).

Dr. Nasser is a Fellow of the American Academy of Pediatrics and serves on the Program Planning Committee for the Group Practice Improvement Network (GPIN).